NDC 59467-679
KLOXXADO
Naloxone Hcl
KLOXXADO is a Nasal Spray in the Human Prescription Drug category. It is labeled and distributed by Hikma Specialty Usa Inc.. The primary component is Naloxone Hydrochloride.
| Product ID | 59467-679_323cf7b3-8ee2-4018-8762-80605b57f6dc |
| NDC | 59467-679 |
| Product Type | Human Prescription Drug |
| Proprietary Name | KLOXXADO |
| Generic Name | Naloxone Hcl |
| Dosage Form | Spray |
| Route of Administration | NASAL |
| Marketing Start Date | 2021-08-03 |
| Marketing Category | NDA / |
| Application Number | NDA212045 |
| Labeler Name | Hikma Specialty USA Inc. |
| Substance Name | NALOXONE HYDROCHLORIDE |
| Active Ingredient Strength | 8 mg/.1mL |
| Pharm Classes | Opioid Antagonist [EPC], Opioid Antagonists [MoA] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2023-12-31 |
Packaging
NDC 59467-679-01
.1 mL in 1 VIAL, SINGLE-DOSE (59467-679-01)
| Marketing Start Date | 2021-08-03 |
| NDC Exclude Flag | N |
| Sample Package? | N |
Drug Details
Trademark Results [KLOXXADO]
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 KLOXXADO 88751046 not registered Live/Pending |
Hikma Pharmaceuticals USA Inc. 2020-01-08 |
© 2025 FDA.report
This site is not affiliated with or endorsed by the FDA.